Valuation: Bayer AG

Market Cap 46.2B 52.65B 43.03B 39.57B 74.18B 5,030B 75.45B 510B 200B 2,494B 198B 193B 8,618B P/E 2026 *
20.3x
P/E 2027 * 15.2x
Enterprise Value 78.05B 88.93B 72.68B 66.85B 125B 8,496B 127B 862B 337B 4,213B 334B 327B 14,558B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
100%
Yield 2026 *
0.48%
Yield 2027 * 1.34%
1 day-0.42%
1 week-1.24%
Current month-2.85%
1 month+0.06%
3 months+28.43%
6 months+4.07%
Current year+27.07%
1 week 45.49
Extreme 45.49
47.72
1 month 45.41
Extreme 45.41
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
3/18/26 A Buy

Director

1,530 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Chairman

2,671 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.42%-1.24%+62.42%-10.25% 52.78B
+1.93%+3.85%+51.05%+166.24% 1,068B
+0.29%+6.43%+60.47%+52.87% 641B
+2.45%+2.77%+39.61%+74.48% 454B
+2.17%+10.22%+41.17%+36.56% 351B
+1.46%+3.87%+39.70%+44.49% 299B
+0.40%+3.59%+19.93%+17.02% 266B
+2.73%+3.50%-25.66%-36.53% 220B
+4.48%+7.33%+30.47%+66.31% 203B
+2.91%+3.10%+18.84%+74.76% 162B
Average +1.92%+3.93%+33.80%+48.60% 371.61B
Weighted average by Cap. +1.92%+4.70%+40.30%+78.81%

Financials

2026 *2027 *
Net sales 45.6B 51.96B 42.47B 39.06B 73.22B 4,965B 74.48B 504B 197B 2,462B 195B 191B 8,506B 46.76B 53.28B 43.54B 40.05B 75.07B 5,090B 76.36B 517B 202B 2,524B 200B 196B 8,721B
Net income 2.13B 2.42B 1.98B 1.82B 3.41B 231B 3.47B 23.49B 9.19B 115B 9.1B 8.9B 397B 2.93B 3.34B 2.73B 2.51B 4.71B 319B 4.79B 32.4B 12.68B 158B 12.54B 12.27B 547B
Net Debt 31.84B 36.28B 29.65B 27.27B 51.12B 3,466B 52B 352B 138B 1,719B 136B 133B 5,939B 28.71B 32.72B 26.74B 24.59B 46.1B 3,126B 46.89B 317B 124B 1,550B 123B 120B 5,356B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
28/07/26 €47.03 -0.42% 1,391,714
27/07/26 €47.23 +2.54% 2,163,091
24/07/26 €46.06 -0.30% 1,486,549
23/07/26 €46.20 -1.64% 2,346,811
22/07/26 €46.97 -1.36% 1,856,037
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.03EUR
Average target price
54.92EUR
Spread / Average Target
+16.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock